According to Laboratorios Farmaceuticos Rovi's latest financial reports the company's current earnings are โฌ0.84 Billion. In 2023 the company made an earning of โฌ0.22 Billion a decrease over its 2022 earnings that were of โฌ0.25 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | โฌ0.19 B | -13.3% |
2023 | โฌ0.22 B | -14.5% |
2022 | โฌ0.25 B | 41.07% |
2021 | โฌ0.18 B | 149.77% |
2020 | โฌ73.38 M | 72.56% |
2019 | โฌ42.52 M | 144.53% |
2018 | โฌ17.39 M | -6.17% |
2017 | โฌ18.53 M | -35.64% |
2016 | โฌ28.79 M | 26.98% |
2015 | โฌ22.67 M | -18.82% |
2014 | โฌ27.93 M | 8.54% |
2013 | โฌ25.73 M | -5.84% |
2012 | โฌ27.33 M | 9.61% |
2011 | โฌ24.93 M | -9.29% |
2010 | โฌ27.49 M |